Posted by Michael Wonder on 12 Mar 2019
Optimism on Orkambi in England as talks to resume
12 March 2019 - Scotland's deal puts pressure on NHS England and NICE.
The UK’s health secretary Matt Hancock met Vertex’s chief executive Jeff Leiden in London yesterday with the aim of breaking the impasse over cystic fibrosis drug Orkambi.
The meeting came after Mr Leiden flew in the from the US last week to appear before MPs in Westminster, telling them his company simply couldn’t accept what NHS England called their ‘fair and final’ pricing offer for the rare disease treatment.
